SCHEMBL7715002

SCHEMBL7715002

Cc1ccccc1P(Cc1ccccc1)c1ccccc1C

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.38
ACHE P22303 1/20 0.38
TP53 P04637 1/20 0.37
CALM1 P0DP23 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
CYP2A6 P11509 1/20 0.34
HTR2A P28223 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
LOXL2 Q9Y4K0 1/20 0.34
HPGD P15428 2/20 0.34
ALDH1A1 P00352 2/20 0.33
KMT2A Q03164 1/20 0.33
HTR7 P34969 1/20 0.33
SCN4A P35499 2/20 0.33
KDM4E B2RXH2 2/20 0.33
HTT P42858 1/20 0.33
MCHR1 Q99705 1/20 0.33
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9016361 0.90 TSHR (0.33) TSHRACHETP53CALM1SMN1; SMN2
SCHEMBL17529868 0.86 HTR7 (0.38) TSHRACHETP53SMN1; SMN2LOXL2
SCHEMBL5596336 0.83 ALDH1A1 (0.45) SMN1; SMN2TAAR1HPGDALDH1A1KMT2A
SCHEMBL17529670 0.83 TSHR (0.38) TSHRACHETP53CALM1SMN1; SMN2
SCHEMBL11216483 0.81 SMN1; SMN2 (0.37) TSHRACHETP53CALM1SMN1; SMN2
SCHEMBL17529866 0.80 LMNA (0.37) TSHRSMN1; SMN2TAAR1ALDH1A1KDM4E
SCHEMBL15657791 0.80 KMT2A (0.36) SMN1; SMN2ALDH1A1KMT2AHTR7SCN4A
SCHEMBL9762826 0.79 SMN1; SMN2 (0.36) TSHRACHETP53SMN1; SMN2HPGD
SCHEMBL10955846 0.77 ACHE (0.36) TSHRACHEALDH1A1HTT
SCHEMBL15661023 0.77 TSHR (0.45) TSHRACHECYP2A6TAAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6369136-B2 MIXING POLYESTER WITH UNSATURATED VINYL MONOMER; EMULSION POLYMERIZATION EASTMAN KODAK COMPANY 2002-04-09 US claimed
US-20010018474-A1 ELECTROPHOTOGRAPHIC TONER BINDERS CONTAINING POLYESTER IONOMERS CITICORP NORTH AMERICA, INC., AS AGENT 2001-08-30 US claimed
EP-2990113-B1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS MARUZEN PETROCHEM CO LTD (JP) 2020-03-25 EP disclosed
EP-2990112-B1 METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE MARUZEN PETROCHEM CO LTD (JP) 2020-03-25 EP disclosed
US-10029241-B2 Method for producing catalyst for cyclic carbonate synthesis MARUZEN PETROCHEMICAL CO., LTD. (JP) 2018-07-24 US disclosed
US-10011621-B2 Method for producing silica gel-immobolized phosphonium salt catalysts MARUZEN PETROCHEMICAL CO., LTD. (JP) 2018-07-03 US disclosed
US-9834536-B2 Method for producing catalyst for cyclic carbonate synthesis NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2017-12-05 US disclosed
US-20160108071-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS MARUZEN PETROCHEMICAL CO., LTD. (JP) 2016-04-21 US disclosed
US-20160067695-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS MARUZEN PETROCHEMICAL CO., LTD. (JP) 2016-03-10 US disclosed
US-20160060242-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2016-03-03 US disclosed
EP-2990114-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS National Institute of Advanced Industrial Science and Technology (JP) 2016-03-02 EP disclosed
EP-2990112-A1 METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE Maruzen Petrochemical Co., Ltd. (JP) 2016-03-02 EP disclosed
EP-2990113-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS Maruzen Petrochemical Co., Ltd. (JP) 2016-03-02 EP disclosed
US-6369136-B2 MIXING POLYESTER WITH UNSATURATED VINYL MONOMER; EMULSION POLYMERIZATION EASTMAN KODAK COMPANY 2002-04-09 US disclosed
US-20010018474-A1 ELECTROPHOTOGRAPHIC TONER BINDERS CONTAINING POLYESTER IONOMERS CITICORP NORTH AMERICA, INC., AS AGENT 2001-08-30 US disclosed
EP-0683786-B1 PROCESS FOR THE PREPARATION OF LITHIUM DIARYLPHOSPHIDES AND ALKYLATED DERIVATIVES THEREOF EASTMAN CHEM CO (US) 1996-12-18 EP disclosed
EP-0683786-A1 PROCESS FOR THE PREPARATION OF LITHIUM DIARYLPHOSPHIDES AND ALKYLATED DERIVATIVES THEREOF. EASTMAN CHEM CO (US) 1995-11-29 EP disclosed
US-5354894-A Treating triarylphosphine with lithium and a primary or secondary amine EASTMAN CHEMICAL COMPANY (US) 1994-10-11 US disclosed
WO-1994018211-A1 PROCESS FOR THE PREPARATION OF LITHIUM DIARYLPHOSPHIDES AND ALKYLATED DERIVATIVES THEREOF EASTMAN CHEMICAL COMPANY (US) 1994-08-18 WO disclosed
US-5288912-A Hydrohalogenation of a triarylphosphine; alkylation; using lithium diarylphosphine as chemical intermediate EASTMAN KODAK COMPANY (US) 1994-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160067695-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS CYCS, CA7, CA9 TSHR 4511/4885ACHE 1194/4885TP53 4382/4885
US-10029241-B2 Method for producing catalyst for cyclic carbonate synthesis CYCS, CA7, CA9 TSHR 4511/4885ACHE 1194/4885TP53 4382/4885
US-20160108071-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS EPHX2, CA4, CA9 TSHR 4242/4885ACHE 372/4885TP53 3231/4885
US-20160060242-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS CA2, PLCB3, PHOSPHO1 TSHR 3716/4885ACHE 1553/4885TP53 3951/4885
US-10011621-B2 Method for producing silica gel-immobolized phosphonium salt catalysts SIK2, SIK3, SIK1 TSHR 3660/4885ACHE 1721/4885TP53 3336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.